Back to Search
SUZANNE SHUSTERMAN, MD
MD
Pediatric Hematology & Oncology Physician
NPI: 1275579237Individual
Specialties, Licenses & Credentials
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
222794(MA)
Research & Publications (14)
Inhibition of tumor growth in a human neuroblastoma xenograft model with TNP-470.
PMID 11107144·Med Pediatr Oncol·2000
7-preclinical
Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study.
PMID 19171714·J Clin Oncol·2009
3-trial
Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.
PMID 16778177·Cancer Res·2006
8-other
Prospects for therapeutic inhibition of neuroblastoma angiogenesis.
PMID 15927358·Cancer Lett·2005
6-review
Methionine aminopeptidase 2 inhibition is an effective treatment strategy for neuroblastoma in preclinical models.
PMID 15814649·Clin Cancer Res·2005
4-observational
Detection of single-copy chromosome 17q gain in human neuroblastomas using real-time quantitative polymerase chain reaction.
PMID 14681326·Mod Pathol·2003
4-observational
Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2.
PMID 14633714·Cancer Res·2003
7-preclinical
The effects of active infant orthopedics on occlusal relationships in unilateral complete cleft lip and palate.
PMID 12943436·Cleft Palate Craniofac J·2003
3-trial
ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.
PMID 12670915·Cancer Res·2003
8-other
Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13.
PMID 12438263·Cancer Res·2002
8-other
Angiogenesis inhibitor TNP-470 during bone marrow transplant: safety in a preclinical model.
PMID 11309354·Clin Cancer Res·2001
7-preclinical
The angiogenesis inhibitor tnp-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease.
PMID 11309349·Clin Cancer Res·2001
7-preclinical
Localization of a hereditary neuroblastoma predisposition gene to 16p12-p13.
PMID 11107108·Med Pediatr Oncol·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 44 BINNEY ST, ROOM G350, DANA FARBER CANCER INSTITUTE
BOSTON, MA 02115 - Phone
- (617) 632-4901
Quick Facts
- NPI
- 1275579237
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 14
Are you this provider?
Claim Your Profile